Reihsaus E, Kohler M, Kraiss S, Oren M, Montenarh M
Department of Biochemistry, University of Ulm, Federal Republic of Germany.
Oncogene. 1990 Jan;5(1):137-45.
In order to contribute to the understanding of the activation of the oncoprotein p53 we determined the metabolic stability of p53 in a variety of non-transformed, immortalized and SV40- and non-SV40-transformed cell lines. In addition, we analyzed the metabolic stability of the SV40 large T antigen in SV40 transformed cell lines. Pulse-chase experiments revealed a low stability (t1/2 = 20 min) of p53 in non-transformed cells and in cells immortalized by the p53 construct pLTRp53cG9. In cells transformed by an activated ras oncogene and pLTRp53cG9 and in methylcholanthrene induced mouse sarcoma cells p53 proved to be progressively more stable with half-lives ranging from 5.5 h to 7 h. Sequential immunoprecipitation with p53- or T antigen specific monoclonal antibodies allowed us to separate T-p53 complexes, uncomplexed p53 and free T antigen in cell extracts from cells transformed by SV40 and pLTRp53cG9. In these transformed cells uncomplexed p53 showed an increased stability (t1/2 = 2.8 h) when compared to p53 from non-transformed cells. Complex formation with T antigen resulted in an additional stabilization of p53 (t1/2 = 13.3 h). Furthermore, T-p53 complex formation also seems to increase the stability of T antigen nearly sixfold. In transformed cells two immunological variants of p53, a PAb246 precipitable and a non-precipitable form showed distinctly different stabilities, indicating a correlation between the ability of p53 subclasses to bind hsc70 protein and their metabolic stability. Moreover, binding to hsc70 correlated with the stabilization of T antigen in CTM cells also where the mutant T antigen is localized exclusively in the cytoplasm. In abortively infected cells p53, even in complex with T antigen, exhibited a relatively low stability (t1/2 = 87 min) indicating that complex formation per se is not sufficient for fully stabilizing p53.
为了有助于理解癌蛋白p53的激活过程,我们测定了p53在多种未转化、永生化以及SV40转化和非SV40转化细胞系中的代谢稳定性。此外,我们分析了SV40大T抗原在SV40转化细胞系中的代谢稳定性。脉冲追踪实验显示,在未转化细胞以及用p53构建体pLTRp53cG9永生化的细胞中,p53的稳定性较低(t1/2 = 20分钟)。在由活化的ras癌基因和pLTRp53cG9转化的细胞以及甲基胆蒽诱导的小鼠肉瘤细胞中,p53的稳定性逐渐增加,半衰期范围为5.5小时至7小时。用p53或T抗原特异性单克隆抗体进行连续免疫沉淀,使我们能够从SV40和pLTRpG9转化的细胞提取物中分离出T - p53复合物、未复合的p53和游离T抗原。在这些转化细胞中,与未转化细胞中的p53相比,未复合的p53显示出稳定性增加(t1/2 = 2.8小时)。与T抗原形成复合物导致p53进一步稳定(t1/2 = 13.3小时)。此外,T - p53复合物的形成似乎也使T抗原的稳定性增加了近六倍。在转化细胞中,p53的两种免疫变体,一种可被PAb246沉淀的形式和一种不可沉淀的形式,显示出明显不同的稳定性,表明p53亚类与hsc70蛋白结合的能力与其代谢稳定性之间存在相关性。此外,在CTM细胞中,与hsc70的结合也与T抗原的稳定相关,在这些细胞中突变的T抗原仅定位于细胞质中。在流产感染的细胞中,p53即使与T抗原形成复合物,也表现出相对较低的稳定性(t1/2 = 87分钟),这表明复合物的形成本身不足以完全稳定p53。